Microcirculatory resistance after primary percutaneous coronary intervention predicts residual myocardial damage: a post hoc analysis from the CLEVER-ACS trial
2 September 2024 (11:25 - 11:35)
Organised by: 

About the speaker

University Hospital Zurich, Zurich (Switzerland)
5 More presentations in this session
Access the full session
The Event
ESC Congress 2024
2 September 2024
11:25 CET
You may be interested in
Congress Session
Congress Session





